WallStreetZenWallStreetZen

NASDAQ: LNTH
Lantheus Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LNTH past earnings growth

How has LNTH's earnings growth performed historically?
Company
6.52%
Industry
62.68%
Market
36.22%
LNTH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LNTH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LNTH's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LNTH past revenue growth

How has LNTH's revenue growth performed historically?
Company
69.36%
Industry
10.68%
Market
13.73%
LNTH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LNTH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LNTH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LNTH earnings and revenue history

Current Revenue
$1.1B
Current Earnings
$33.4M
Current Profit Margin
3%

LNTH Return on Equity

Current Company
6.4%
Current Industry
11.8%
Current Market
22.1%
LNTH's Return on Equity (6.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LNTH announces earnings.

LNTH Return on Assets

Current Company
2.6%
Current Industry
3.7%
LNTH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LNTH Return on Capital Employed

Current Company
2.83%
Current Industry
6.8%
LNTH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LNTH vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LNTH$1.12B$87.90M$33.37M+27.85%-31.71%
ALKS$1.46B$199.13M$102.99M+7.41%N/A
ITCI$365.84M-$183.66M-$184.37M+533.66%N/A
PRGO$4.63B$536.10M-$67.70M-1.20%N/A
ELAN$4.32B$849.00M-$98.00M+7.89%N/A
View Top Pharmaceutical Stocks

LNTH earnings dates

Next earnings date
Nov 1, 2023

Lantheus Holdings Earnings & Revenue FAQ

What were LNTH's earnings last quarter?

On Invalid Date, Lantheus Holdings (NASDAQ: LNTH) reported Q2 2023 earnings per share (EPS) of $1.38, up 119.05% year over year. Total Lantheus Holdings earnings for the quarter were $94.13 million. In the same quarter last year, Lantheus Holdings's earnings per share (EPS) was $0.63.

If you're new to stock investing, here's how to buy Lantheus Holdings stock.

What was LNTH's earnings growth in the past year?

As of Q3 2023, Lantheus Holdings's earnings has grown 6.52% year over year. This is 56.16 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 62.68%. Lantheus Holdings's earnings in the past year totalled $33.37 million.

What is LNTH's earnings date?

Lantheus Holdings's earnings date is Invalid Date. Add LNTH to your watchlist to be reminded of LNTH's next earnings announcement.

What was LNTH's revenue last quarter?

On Invalid Date, Lantheus Holdings (NASDAQ: LNTH) reported Q2 2023 revenue of $321.70 million up 43.79% year over year. In the same quarter last year, Lantheus Holdings's revenue was $223.72 million.

What was LNTH's revenue growth in the past year?

As of Q3 2023, Lantheus Holdings's revenue has grown 69.36% year over year. This is 58.68 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.68%. Lantheus Holdings's revenue in the past year totalled $1.12 billion.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.